About
Atlas Molecular Pharma discovers and develops innovative pharmacological chaperone-based therapeutics for the treatment of rare and ultra-rare diseases, licensing these drugs to larger partners for market delivery.
Explore Atlas Molecular Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.